This is an excerpt from a post published by thenationalpulse.com.
Judicial Watch has just revealed that the US Department of Health and Human Services (HHS), specifically the National Institutes of Health (NIH), spent almost $3 million in federal funds on a University of Pittsburgh project to harvest human fetal organs and tissue, particularly from minority fetuses, and even from full-term babies.
Judicial Watch is representing The Center for Medical Progress (CMP) in a Freedom of Information Act (FOIA) lawsuit, suing HHS following its failure to respond to a FOIA request on April 28, 2020, which sought information including University of Pittsburgh grant applications for a “tissue hub and collection site.” CMP and Judicial Watch have now obtained 252 pages of new documentation from HHS as part of the lawsuit. The documents uncover the university’s project to “become a ‘Tissue Hub’ for human fetal tissue ranging from 6 to 42 weeks gestation.”
The documentation concerning the University of Pittsburgh (Pitt) project has numerous bombshells.
“The aims of the project listed in the original 2015 proposal were to ‘develop a pipeline to the acquisition, quality control and distribution of human genitourinary [urinary and genital organs and functions] samples obtained throughout development (6-42 weeks gestation). … [and] generate an ongoing resource to distribute fresh developmental human genitourinary samples from various stages (6-42 weeks) to the GUDMAP [GenitoUrinary Development Molecular Anatomy Project] Atlas projects.’”
In the proposal, Pitt said that it had in fact been “collecting fetal tissue for over 10 years … include[ing] liver, heart, gonads, legs, brain, genitourinary tissues including kidneys, ureters and bladders,” and in 2015 said, “we have disbursed over 300 fresh samples collected from 77 cases. The collections can be significantly ramped up as material could have been accrued from as many as 725 cases last year.” The documents further say that Pitt’s Health Sciences Tissue Bank is embedded in the Department of Pathology, which thus provides “rapid access to very high quality tissue and biological specimens.”
Continue reading the complete version of this post at thenationalpulse.com.
Author: Raheem Kassam
Raheem Kassam is the Editor-in-Chief of the National Pulse, and former senior advisor to Brexit leader Nigel Farage. Kassam is the best-selling author of ‘No Go Zones’ and ‘Enoch Was Right’, a co-host at the War Room: Impeachment podcast, a Lincoln fellow at the Claremont Institute, and a fellow at the Bow Group think tank. Kassam is an academic advisory board member at the Institut des Sciences Sociales, Economiques et Politiques in Lyon, France. He resides in Washington, D.C.
This is an excerpt from thenationalpulse.com shared in accordance with fair use terms for non-profit educational purposes.